Extraintestinal Manifestations of Clostridioides difficile Infections: An Overview
- PMID: 40723972
- PMCID: PMC12291952
- DOI: 10.3390/antibiotics14070670
Extraintestinal Manifestations of Clostridioides difficile Infections: An Overview
Abstract
Introduction: Clostridioides difficile (C. difficile) is primarily associated with colonic disease, including pseudomembranous colitis. However, in rare instances, it may cause extraintestinal infectious and non-infectious manifestations, particularly in immunocompromised patients or those with significant underlying conditions.
Search methods: A literature review was performed using PubMed, Embase, and Researchgate databases up to 15 February 2025. The following search strings were used: "extraintestinal manifestations", "extracolonic manifestations", "extraintestinal infections", "extracolonic infections", "Clostridium difficile", and "Clostridioides difficile".
Results: Extraintestinal manifestations of C. difficile appear to represent fewer than 1% of all reported infections. The most frequently reported infectious complications include bacteremia and abdominopelvic infections and abscesses, often involving polymicrobial cultures, with the isolation of C. difficile alongside microorganisms typically found in the normal intestinal microbiota. Rare non-infectious cases, such as reactive arthritis, have also been described. The underlying pathogenetic mechanism is believed to involve disruption of the intestinal barrier and translocation of bacteria or toxins to sterile sites.
Conclusions: Though rare, extraintestinal C. difficile manifestations pose important clinical challenges. Better understanding of their mechanisms is essential for early recognition and appropriate management. Further research is warranted to define potential mechanisms and therapeutic approaches.
Keywords: Clostridioides difficile; Clostridium difficile; extraintestinal infections; extraintestinal manifestations.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2. Cochrane Database Syst Rev. 2023. PMID: 37096495 Free PMC article.
-
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004610. doi: 10.1002/14651858.CD004610.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. doi: 10.1002/14651858.CD004610.pub3. PMID: 15674956 Updated.
-
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. doi: 10.1002/14651858.CD004610.pub3. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Sep 07;(9):CD004610. doi: 10.1002/14651858.CD004610.pub4. PMID: 17636768 Updated.
-
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4. Cochrane Database Syst Rev. 2017. PMID: 29257353 Free PMC article.
-
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.Cochrane Database Syst Rev. 2013 May 31;(5):CD006095. doi: 10.1002/14651858.CD006095.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Dec 19;12:CD006095. doi: 10.1002/14651858.CD006095.pub4. PMID: 23728658 Updated.
References
-
- Hall I.C. Intestinal flora in New-Born infants. Am. J. Dis. Child. 1935;49:390. doi: 10.1001/archpedi.1935.01970020105010. - DOI
Publication types
LinkOut - more resources
Full Text Sources